| Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew Archiv der Pharmazie 349 (8), 627-637, 2016 | 73 | 2016 |
| Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors R Sasidharan, SC Baek, MS Leelabaiamma, H Kim, B Mathew Biomedicine & Pharmacotherapy 106, 8-13, 2018 | 44 | 2018 |
| Monoamine oxidase inhibitors: Perspective design for the treatment of depression and neurological disorders B Mathew, G E Mathew, J Suresh, G Ucar, R Sasidharan, S Anbazhagan, ... Current Enzyme Inhibition 12 (2), 115-122, 2016 | 35 | 2016 |
| Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: Synthesis and biochemical investigations R Sasidharan, BH Eom, JH Heo, JE Park, MA Abdelgawad, A Musa, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 188-197, 2021 | 29 | 2021 |
| In Vitro Study of the Interaction Between HSA and 4‐Bromoindolylchalcone, a Potent Human MAO‐B Inhibitor: Spectroscopic and Molecular Modeling Studies OA Chaves, R Sasidharan, CHC dos Santos de Oliveira, SL Manju, M Joy, ... ChemistrySelect 4 (3), 1007-1014, 2019 | 18 | 2019 |
| Anti-inflammatory effect of synthesized indole-based chalcone (2E)-3-(4-bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one: an in vitro and in vivo studies R Sasidharan, M Sreedharannair Leelabaiamma, R Mohanan, SP Jose, ... Immunopharmacology and Immunotoxicology 41 (6), 568-576, 2019 | 12 | 2019 |
| MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer’s Disease R Sasidharan, R Mohanan, N Kukreti, P Raj, MA Abdelgawad, ... Neurochemical Research, 1-11, 2023 | | 2023 |
